Review
Open access
Jul 2026
XPO1: From basic research to clinical treatment (Review)
The present review focuses on the clinical translation of SINE drugs, especially selinexor (KPT-330), in hematologic and solid tumors, critically assesses the limitations of monotherapy and explores the mechanistic basis for synergistic combination strategies.
Changyan Yang, Jing Zhu, Xiang Zheng et al.
· Oncology Report · 0 citations